May 19, 2024 — A physician-initiated prospective, randomized clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI) found that early cardiac resynchronization therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB).
